Voice/Vocal Biomarkers Market To Quadruple In Size By 2035: Analysis Of Key Industry Trends, Opportunities And Challenges With Competition Profiling

(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in the voice/vocal biomarker sector include early disease detection and prevention, especially for neurological, mental health, and respiratory conditions. Leveraging AI and ML, this non-invasive technology enables remote, real-time health monitoring, appealing to healthcare providers aiming for cost-effective and scalable diagnostics.

Dublin, Sept. 19, 2025 (GLOBE NEWSWIRE) -- The "Voice/Vocal Biomarker Market - A Global and Regional Analysis: Focus on Platform Type, Application, Indication, End User, and Regional Analysis - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets's offering.
The Voice/Vocal Biomarker Market, valued at USD 1.24 Billion in 2025, is projected to reach USD 5.39 Billion by 2035, growing at a CAGR of 15.81%. This market is revolutionizing healthcare diagnostics through the analysis of voice characteristics, powered by advancements in artificial intelligence (AI) and machine learning (ML).

Leading companies such as Sonde Health and Canary Speech are pioneering AI-driven solutions to detect neurological, psychiatric, and cognitive disorders by analyzing speech patterns. These technologies offer non-invasive methods to monitor conditions like Parkinson's, Alzheimer's, depression, and anxiety by assessing vocal features like pitch and speech rate.

One of the primary advantages of voice biomarkers is their non-invasive nature; short voice recordings can diagnose health issues early on. This accessibility is crucial for remote monitoring and has led to strategic partnerships. For example, Sonde Health's collaboration with Qualcomm aims to incorporate vocal biomarkers into mobile platforms, while companies like Winterlight and Cambridge Cognition focus on cognitive impairment via voice analysis.

The application of vocal biomarker technology in healthcare is expanding, particularly in telemedicine, cognitive health, and mental health monitoring. These advancements enable earlier interventions, driving a paradigm shift in patient management and wellness programs. Ensuring data privacy remains paramount, with companies adhering to regulations like GDPR and HIPAA to safeguard sensitive health data.

Segmentation insights reveal that cloud-based platforms dominate the market, providing necessary infrastructure for large-scale voice data analysis. Moreover, mental health applications lead the market, as voice analysis enables real-time monitoring of emotional wellbeing. Hospitals are major end-users, leveraging this technology for advanced diagnostics and patient care.

Geographically, the Asia-Pacific region is experiencing rapid growth, with heightened integration of AI and ML in mobile health devices and telehealth services. China and India are at the forefront, driven by technological adoption and increasing healthcare investments.

Recent developments include Beyond Verbal's partnership with Mayo Clinic for Alzheimer's detection and Ellipsis Health's funding round to enhance AI voice agents for care management. These innovations underscore the market's potential to transform diagnostics and preventive healthcare.

Opportunities abound in early disease detection and prevention, with voice biomarkers enabling timely interventions in neurological, mental health, and respiratory conditions. Companies like Vocalis Health are leveraging AI for Parkinson's detection, while Sonde Health monitors emotional distress to preempt chronic mental health issues.

In conclusion, the voice/vocal biomarker market is set to redefine healthcare diagnostics by providing a non-invasive, accessible, and effective solution for early detection and continuous monitoring. As AI technologies advance, the integration of vocal biomarkers into healthcare systems promises to enhance patient outcomes and efficiency.

For more insights, explore our comprehensive report detailing market trends, drivers, and technological innovations driving this dynamic market forward.

Key Attributes

Report Attribute	Details
No. of Pages	131
Forecast Period	2025-2035
Estimated Market Value (USD) in 2025	$1.24 Billion
Forecasted Market Value (USD) by 2035	$5.39 Billion
Compound Annual Growth Rate	15.8%
Regions Covered	Global

Key Topics Covered:

• 1 Global Voice/Vocal Biomarker Market: Industry Outlook
  • 1.1 Industry Outlook
  • 1.2 Market Dynamics
  • 1.3 Trends
• 2 Platform Type
  • 2.1 Overview
  • 2.2 Growth Share Matrix
• 3 Application Type
  • 3.1 Overview
  • 3.2 Growth Share Matrix
• 4 Indication
  • 4.1 Overview
  • 4.2 Growth Share Matrix
• 5 End User
  • 5.1 Overview
  • 5.2 Growth Share Matrix
• 6 Region
  • 6.1 North America
  • 6.2 Europe
  • 6.3 Asia-Pacific
  • 6.4 Latin America
  • 6.5 Middle East and Africa
• 7 Competitive Landscape and Company Profiles
  • 7.1 Company Position Analysis in the Market
  • 7.2 Company Profiles
• 8 Research Methodology
  • 8.1 Data Sources
  • 8.2 Market Estimation and Forecast

Companies Featured

• audEERING GmbH
• Biosensics
• Canary Speech, Inc.
• Evocal Health GmbH.
• Kintsugi Mindful Wellness, Inc.
• PST Inc.
• Sonde Health
• Sound Health
• VoiceMed Italia srl
• Zana Technologies GmbH

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Voice/Vocal Biomarker Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN19092025004107003653ID1110085413